AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

Co-Host: Brian Shuch, MD At the conclusion of these activities, participants will be able to: 1. State the criteria for genetic testing of prostate cancer patients, the gene panels available, and opt...

18 Marras 201925min

Co-Host: Vitaly Margulis, MD At the conclusion of these activities, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and bene...

13 Marras 201924min

The American Urological Association (AUA) and Società Italiana di Urologia (SIU) have collaborated to develop an independent educational activity to review the latest updates in immuno-oncology. This...

5 Marras 201950min

Co-Host: William Huang, MD At the conclusion of these activities, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both compl...

31 Loka 201935min

Take Home Messages: Female Urology/Incontinence Ariana Smith, MD University of Pennsylvania Take Home Messages: Reconstruction Giulia Lane, MD Urology Fellow, FPMRS University of Michigan

25 Loka 201916min

Co-Host: Maxwell Meng, MD At the conclusion of these activities, participants will be able to: 1. Identify treatments for non-metastatic and metastatic CRPC and describe the proper order for their ad...

17 Loka 201938min

Co-Host: Robert Svatek, MD At the conclusion of these activities, participants will be able to: 1. Recognize both historic and newer immunotherapy options in the treatment of bladder cancer. 2. Descr...

10 Loka 201931min

Co-Host: Kelvin Moses, MD At the conclusion of these activities, participants will be able to: 1. Identify the active agents and their mechanism of action in the management of metastatic HSPC. 2. Des...

3 Loka 201923min